Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4953-4954

  Daurel, Claire ^a   Fiant, Anne Lise ^a   Brémont, Sylvie ^b   Courvalin, Patrice ^b   Leclercq, Roland ^c  

^a CHU CÔTE DE NACRE   (France)

^b INSTITUT PASTEUR   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; IMIPENEM; TIGECYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; ENTEROBACTER; ENTEROBACTER HORMAECHEI; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE;

EID: 70350316740     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01592-08     Document Type: Letter

References (9)

1. Anthony, K. B., N. O. Fishman, D. R. Linkin, L. B. Gasink, P. H. Edelstein, and E. Lautenbach. 2008. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin. Infect. Dis. 46:567-570.
2. Daly, M. W., D. J. Riddle, N. A. Ledeboer, W. M. Dunne, and D. J. Ritchie. 2007. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy 27:1052-1057.
3. Keeney, D., A. Ruzin, and P. A. Bradford. 2007. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb. Drug Resist. 13:1-6. (Pubitemid 46833752)
4. Keeney, D., A. Ruzin, F. McAleese, E. Murphy, and P. A. Bradford. 2008. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J. Antimicrob. Chemother. 61:46-53.
5. Kelesidis, T., D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas. 2008. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J. Antimicrob. Chemother. 62:895-904.
6. Milohanic, E., P. Glaser, J. Y. Coppee, L. Frangeul, Y. Vega, J. A. Vazquez-Boland, F. Kunst, P. Cossart, and C. Buchrieser. 2003. Transcriptome analysis of Listeria monocytogenes identifies three groups of genes differently regulated by PrfA. Mol. Microbiol. 47:1613-1625.
7. Peleg, A. Y., B. A. Potoski, R. Rea, J. Adams, J. Sethi, B. Capitano, S. Husain, E. J. Kwak, S. V. Bhat, and D. L. Paterson. 2007. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother. 59:128-131.
8. Reid, G. E., S. A. Grim, C. A. Aldeza, W. M. Janda, and N. M. Clark. 2007. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy 27:1198-1201.
9. Schafer, J. J., D. A. Goff, K. B. Stevenson, and J. E. Mangino. 2007. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy 27:980-987.